Equities
  • Price (EUR)25.60
  • Today's Change0.00 / 0.00%
  • Shares traded86.00
  • 1 Year change+15.32%
  • Beta0.9815
Data delayed at least 15 minutes, as of Feb 12 2026 08:55 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Kaneka Corp is a Japan-based company engaged in four business segments. The Material Solutions Unit segment includes general purpose vinyl chloride resin, caustic soda, polyvinyl chloride special resin, modifier, epoxy masterbatches, biodegradable polymer and modified silicone polymer. Quality of Life Solutions Unit segment includes styrene-based foam resin and molded product, styrene-based foam extrusion board, polyolefin foam, solar circuit construction method, polyimide film, optical material, graphite sheet, solar cells, storage batteries for housing, and acrylic synthetic fiber. The Health Care Solutions Unit segment includes medical devices, low molecular weight pharmaceutical raw materials, Active Pharmaceutical Ingredient (API) and biopharmaceuticals. The Nutrition Solutions Unit segment includes functional food ingredients, lactic acid bacteria, margarine, shortening, baker's yeast, spices, antifreeze ingredients, dairy products, functional fertilizers and feeds.

  • Revenue in JPY (TTM)802.43bn
  • Net income in JPY26.01bn
  • Incorporated1949
  • Employees11.51k
  • Location
    Kaneka CorpNakanoshima Festival Tower2-3-18, Nakanoshima, Kita-kuOSAKA-SHI 530-8288JapanJPN
  • Phone+81 662265050
  • Fax+81 662265037
  • Websitehttp://www.kaneka.co.jp
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4118:TYO since
announced
Transaction
value
ZEON MEDICAL INC-Medical Equipment Business in Fields of Gastrointestinal & Circulatory SystemsAnnounced12 Nov 202512 Nov 2025Announced15.86%--
Data delayed at least 15 minutes, as of Feb 12 2026 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.